AP NEWS

$1.5+ Billion Worldwide Cell Line Development Services Market Outlook to 2027 - Analysis by Cell Type and Application - ResearchAndMarkets.com

January 29, 2019

DUBLIN--(BUSINESS WIRE)--Jan 29, 2019--The “Cell Line Development Services Global Market” report has been added to ResearchAndMarkets.com’s offering.

According to the report, the Cell Line Development services market is expected to grow at a high double digit CAGR to reach $1,519.5 million by 2027.

Increasing demand for biologics and biosimilars, growing incidence rate of oncology and immunological disorder and growth in research activities related to the diseases are driving the market.

Technological improvements in development, manufacturing, screening technologies and assays are giving immense growth opportunity for the market.

However, complexities in development of stable cell lines and high risk of contamination due to complex purification methods are restraining the market.

Furthermore, stringent and complex regulations and high cost and technical requirement to adhere with accreditations such as GMP are posing threat to the industry.

Some of the major companies in the cell line development market include JSR Life Science (Selexis), Lonza (Switzerland), Boehringer Ingelheim (Germany), Catalent (U.S.), Samsung Biologics (South Korea), Fujifilm Diosynth (Japan), Patheon (Thermo Fisher Scientific) (U.S.), AGC Biologics (U.S.), Merck KGaA (Germany), Rentschler Biotech (Germany), Genscript Biotech (China), Horizon Discovery (U.K.), Sartoris AG (France), Wuxi Apptec (China), and Eurofins (Luxembourg).

Some of the other players are Syngene (India), Evotec (Germany), Lake Pharma (U.S.), TCG Lifescience (India), Cobra Biologics (U.K.), Abzena (U.K.), JHL Biotech (Taiwan), Charles River Laboratories (U.S.), Mabplex (U.S.), Trenzyme (Germany), Atum (U.S.), ATCC (U.S.).

Topics Covered

1 Executive Summary

2 Market Dynamics

3 Cell Line Development

4 Host Cell Lines

5 Cell Line Development Services, By Cell Type

6 Cell Line Development Services, By Application

7 Key Developments

8 Market Share Analysis

9 Company Profiles

AGC Biologics Boehringer Ingelheim Catalent Inc. Eurofins Scientific Group Genscript Biotech Corporation Horizon Discovery Group PLC JHL Biotech Inc. JSR Life Sciences (Selexis SA) Lonza Group Merck KGaA Patheon (Thermo Fisher Scientific) Rentschler Biopharma SE Samsung Biologics Sartorius AG Wuxi Biologics (Wuxi Apptec)

For more information about this report visit https://www.researchandmarkets.com/research/fv7487/1_5_billion?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190129005394/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology

KEYWORD:

INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/29/2019 04:57 AM/DISC: 01/29/2019 04:57 AM

http://www.businesswire.com/news/home/20190129005394/en

AP RADIO
Update hourly